Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Return on Assets (2017 - 2025)

Protagonist Therapeutics' Return on Assets history spans 9 years, with the latest figure at 0.19% for Q4 2025.

  • For Q4 2025, Return on Assets fell 60.0% year-over-year to 0.19%; the TTM value through Dec 2025 reached 0.19%, down 60.0%, while the annual FY2025 figure was 0.18%, 68.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.19% at Protagonist Therapeutics, down from 0.06% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.41% in Q4 2024 and bottomed at 0.57% in Q1 2023.
  • The 5-year median for Return on Assets is 0.01% (2021), against an average of 0.05%.
  • The largest annual shift saw Return on Assets soared 91bps in 2024 before it crashed -60bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.0% in 2021, then crashed by -70478bps to 0.48% in 2022, then soared by 54bps to 0.22% in 2023, then skyrocketed by 283bps to 0.41% in 2024, then tumbled by -147bps to 0.19% in 2025.
  • Per Business Quant, the three most recent readings for PTGX's Return on Assets are 0.19% (Q4 2025), 0.06% (Q3 2025), and 0.07% (Q2 2025).